{"disease":{"id":"pituitary-diseases","name":"pituitary diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04951557","title":"Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03665064","title":"Long Term Outcome Study in Patients With Pituitary Disorders","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03344458","title":"A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"Ascendis Pharma A/S","has_results":true},{"nct_id":"NCT02781727","title":"A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Ascendis Pharma Endocrinology Division A/S","has_results":true},{"nct_id":"NCT03305016","title":"A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Ascendis Pharma Endocrinology Division A/S","has_results":true},{"nct_id":"NCT04902235","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT04897802","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT02782208","title":"Lipolytic Effects of GH in Hypopituitary Patients in Vivo","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"University of Aarhus","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}